Professional Overview
Pek Lum is an accomplished biotech entrepreneur and executive with over 20 years of experience driving innovation in the life sciences industry. As the Founder and CEO of Auransa Inc., she leverages her deep expertise in computational biology, drug discovery, and strategic advisory to advance cutting-edge therapies for unmet medical needs.
Experience Summary
Current Role
As the Founder and CEO of Auransa Inc. since 2014, Pek leads a team of world-class scientists and engineers in developing AI-powered drug discovery platforms. Under her leadership, Auransa has pioneered the use of machine learning and systems biology to accelerate the identification and development of novel therapeutic candidates. Pek's visionary approach has positioned Auransa as a trailblazer in the emerging field of AI-driven drug discovery.
Pek also serves as an External Advisory Board Member at the Schaefer School of Engineering and Science at Stevens Institute of Technology, where she provides strategic guidance on curriculum development and research initiatives. Additionally, she acts as an Advisor to Sequence Bio, a genomics research company.
Career Progression
Prior to founding Auransa, Pek held senior scientific and advisory roles at prominent life sciences organizations. As the Senior Director at iPierian, she led the advancement of stem cell-based therapies. Earlier in her career, Pek served as the Scientific Director at Rosetta/Merck, where she contributed to the development of computational biology tools and methods for drug discovery.
Pek's extensive experience also includes serving as an Advisor to Bayes Impact, a non-profit dedicated to social impact projects, and The Michael J. Fox Foundation for Parkinson's Research, where she provided strategic guidance on research initiatives.
Academic Background
Pek holds a Ph.D. in Computational Biology from the University of Washington, where she specialized in the development of novel algorithms and computational methods for the analysis of biological systems.
Areas of Expertise
- Computational biology and systems biology
- AI-powered drug discovery and development
- Translational research and clinical development
- Strategic advisory and business leadership
Professional Impact
Under Pek's visionary leadership, Auransa has established itself as a leading force in the application of AI and computational biology to drug discovery. The company's innovative platforms have generated a robust pipeline of promising therapeutic candidates, attracting significant investment and industry recognition.
Pek's expertise and thought leadership have also been instrumental in shaping the direction of the life sciences industry. Through her advisory roles and collaborations, she has contributed to the advancement of cutting-edge research and the development of transformative technologies in the field.
Conclusion
Pek Lum's remarkable career trajectory and pioneering work in AI-driven drug discovery have positioned her as a trailblazer in the biotech industry. Her unwavering commitment to innovation and her ability to translate scientific insights into tangible solutions make her a valuable asset to the organizations she serves. Pek's visionary leadership and interdisciplinary expertise continue to drive meaningful progress in the quest for novel therapies and improved patient outcomes.
